Illumina’s COVIDSeq Test enables qualitative detection of SARS-CoV-2 RNA from respiratory specimens.
The goal of the guidance is to ensure that manufacturers are prepared to report adverse events during a pandemic.
The continued threat and spread of COVID-19 across the globe has led to seismic uncertainty for every industry.
Don’t miss this opportunity to learn how your company can effectively push its product to the finish line.
The prescription-only diagnostic allows patients to self-collect saliva samples to test for SARS-CoV-2.
COVID-19 requires us to rethink our current device disinfection procedure.
It is the first federal approval for a test that uses saliva as the primary test biomaterial for COVID-19.
Advanced Sterilization Products received an EUA for the STERRAD Sterilization Cycles.
The system will allow healthcare professionals to reuse the critical care products up to 20 times during the COVID-19 pandemic.
Diagnostic companies are hustling to increase availability of testing.